Gonadotropin-releasing Hormone Agonist Overuse: Urologists’ Response to Reimbursement and Characteristics Associated with Persistent Overuse

BACKGROUND: Medicare reimbursement cuts have been associated with declining Gonadotropin-releasing Hormone (GnRH) agonist overuse in localized prostate cancer. Medical school affiliation and foreign training have been associated with persistent overuse. However, physician-level prescribing changes a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellis, Shellie D., Nielsen, Matthew E., Carpenter, William R., Jackson, George L., Wheeler, Stephanie B., Liu, Huan, Weinberger, Morris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430363/
https://www.ncbi.nlm.nih.gov/pubmed/25849354
http://dx.doi.org/10.1038/pcan.2015.10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430363/
https://www.ncbi.nlm.nih.gov/pubmed/25849354
http://dx.doi.org/10.1038/pcan.2015.10

Ejemplares similares